Kandice J Varcin1, Shafali S Jeste. 1. aTelethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia bUCLA Semel Institute of Neuroscience and Human Behavior, David Geffen School of Medicine, Los Angeles, California, USA.
Abstract
PURPOSE OF REVIEW: We review studies of infants at risk for autism spectrum disorder (ASD), proposing that the earliest manifestations of disrupted brain development can shed light on prebehavioural markers of risk and mechanisms underlying the heterogeneity of ASD. RECENT FINDINGS: Prospective, longitudinal studies of infants at risk for ASD have revealed that behavioural signs of ASD are generally not observed until the second year of life. The developmental signs within the first year are often subtle and rooted in processes outside the core diagnostic domains of ASD, such as motor and visual perceptual function. However, studies examining early brain development and function have identified a myriad of atypicalities within the first year that are associated with risk for ASD. SUMMARY: Longitudinal studies of high-risk infants provide a unique opportunity to identify and quantify the sources of the atypical development and developmental heterogeneity of ASD. Integration of assays of behaviour and brain in the first year of life, expansion of the definition of high risk, and coordinated efforts in multisite investigations to adequately power integrative studies will lead to new insights into mechanisms of atypical development and, ultimately, the ideal timing and target for interventions that aim to attenuate delays or impairments.
PURPOSE OF REVIEW: We review studies of infants at risk for autism spectrum disorder (ASD), proposing that the earliest manifestations of disrupted brain development can shed light on prebehavioural markers of risk and mechanisms underlying the heterogeneity of ASD. RECENT FINDINGS: Prospective, longitudinal studies of infants at risk for ASD have revealed that behavioural signs of ASD are generally not observed until the second year of life. The developmental signs within the first year are often subtle and rooted in processes outside the core diagnostic domains of ASD, such as motor and visual perceptual function. However, studies examining early brain development and function have identified a myriad of atypicalities within the first year that are associated with risk for ASD. SUMMARY: Longitudinal studies of high-risk infants provide a unique opportunity to identify and quantify the sources of the atypical development and developmental heterogeneity of ASD. Integration of assays of behaviour and brain in the first year of life, expansion of the definition of high risk, and coordinated efforts in multisite investigations to adequately power integrative studies will lead to new insights into mechanisms of atypical development and, ultimately, the ideal timing and target for interventions that aim to attenuate delays or impairments.
Authors: Jason J Wolff; Guido Gerig; John D Lewis; Takahiro Soda; Martin A Styner; Clement Vachet; Kelly N Botteron; Jed T Elison; Stephen R Dager; Annette M Estes; Heather C Hazlett; Robert T Schultz; Lonnie Zwaigenbaum; Joseph Piven Journal: Brain Date: 2015-05-03 Impact factor: 13.501
Authors: Tony Charman; Gregory S Young; Jessica Brian; Alice Carter; Leslie J Carver; Katarzyna Chawarska; Suzanne Curtin; Karen Dobkins; Mayada Elsabbagh; Stelios Georgiades; Irva Hertz-Picciotto; Ted Hutman; Jana M Iverson; Emily J Jones; Rebecca Landa; Suzanne Macari; Daniel S Messinger; Charles A Nelson; Sally Ozonoff; Celine Saulnier; Wendy L Stone; Helen Tager-Flusberg; Sara Jane Webb; Nurit Yirmiya; Lonnie Zwaigenbaum Journal: Autism Res Date: 2016-07-15 Impact factor: 5.216
Authors: Jocelyn J LeBlanc; Geneva DeGregorio; Eleonora Centofante; Vanessa K Vogel-Farley; Katherine Barnes; Walter E Kaufmann; Michela Fagiolini; Charles A Nelson Journal: Ann Neurol Date: 2015-09-18 Impact factor: 10.422
Authors: Emily J H Jones; Teodora Gliga; Rachael Bedford; Tony Charman; Mark H Johnson Journal: Neurosci Biobehav Rev Date: 2013-12-18 Impact factor: 8.989
Authors: Taylor R Thomas; Tanner Koomar; Lucas G Casten; Ashton J Tener; Ethan Bahl; Jacob J Michaelson Journal: Transl Psychiatry Date: 2022-06-13 Impact factor: 7.989
Authors: Jessica R Shoaff; Kevin Nugent; Thomas Berry Brazelton; Susan A Korrick Journal: Paediatr Perinat Epidemiol Date: 2020-09-19 Impact factor: 3.980
Authors: Rachael Bedford; Teodora Gliga; Elizabeth Shephard; Mayada Elsabbagh; Andrew Pickles; Tony Charman; Mark H Johnson Journal: Mol Autism Date: 2017-09-22 Impact factor: 7.509